Experiencing and maintaining weight loss is a struggle for millions of people all over the world
While Semaglutide is a potent GLP-1 agonist, Tirzepatide functions as a dual GIP/GLP-1 receptor agonist, which some clinical trials suggest may provide slightly enhanced weight loss outcomes
Key Features: Contains Akkermansia muciniphila, a beneficial gut bacteria strain that enhances the mucin layer of the gut lining, improving gut barrier integrity and reducing intestinal permeability
The immunomodulatory effects make this medication a promising treatment agent for autoimmune diseases, infectious diseases, & immune-mediated conditions such as allergies & asthma
Semaglutide is a drug contained in other products, such as Ozempic, an injection used to control blood sugars, and Wegovy, an oral or injectable medication indicated for weight loss